Cytomegalovirus manipulation of functional cortical tissue development
巨细胞病毒操纵功能性皮质组织发育
基本信息
- 批准号:10197788
- 负责人:
- 金额:$ 38.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-09 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAcetyltransferaseAddressAntiviral AgentsAntiviral TherapyAstrocytesBiologicalBiologyBrainCell CycleCell Differentiation processCell modelCell physiologyCellsChildComplexCongenital AbnormalityCytomegalovirusCytomegalovirus InfectionsDNA DamageDNA biosynthesisDevelopmentEnvironmentEventFibroblastsGene ExpressionGoalsHealthHerpesviridaeHumanImageInfectionKnowledgeLifeLong-Term CareLyticMass Spectrum AnalysisMethodsModificationMolecularMolecular and Cellular BiologyNervous System TraumaNeuraxisNeuronsOrganoidsParentsPathogenesisPhosphotransferasesPopulationPredispositionPregnancyPregnant WomenProtein IsoformsProteinsRegulationResearchRoleSocietiesTechniquesTeratogenic effectsTestingTissue EngineeringTissue ModelTissuesToxic effectTumor Suppressor ProteinsUnited StatesVaccine TherapyViralViral GenesVirionVirusbasebrain morphologychronic infectionclinically relevantfetalinnovationkinase inhibitorlive cell imagingmaribavirmigrationnerve stem cellnervous system developmentneurogenesispreventprotective effectprotein protein interactionrelating to nervous systemresponsestem cell divisionstem cell proliferationstem cellssynaptic functiontranscriptometwo-dimensionalviral DNA
项目摘要
PROJECT SUMMARY
Human cytomegalovirus (hCMV) infects much of the world’s population and establishes a life-long
persistent infection defined by both lytic and latent states, and hCMV continues to be a significant issue in
human health. hCMV is the leading cause of non-heritable birth defects in the United States and likely around
the world. If the virus crosses the placental barrier, hCMV replicates in fetal neural progenitor cells resulting
in central nervous system damage. Several antiviral treatments exist but are not approved for use during
pregnancy due to toxicity and potential teratogenic effects. The collaborative project described in this
application was initiated to address the significant deficiencies in understanding the underlying pathogenesis
of congenital hCMV infection and the lack of antiviral approaches.
hCMV expresses a viral kinase, pUL97 that regulates diverse viral and cellular processes and can be
inhibited by the antiviral compound, maribavir. One target of pUL97 that is important for hCMV replication and
maribavir activity is the cellular Tip60 acetyltransferase. Tip60 is a tumor suppressor, manipulated by
numerous viruses, and regulates stem cell renewal and differentiation during tissue development. Tip60 is
expressed in several isoforms and is part of larger multiprotein Tip60 complexes where specific functional
activity is determined by the associated proteins.
The objectives of this proposal are twofold: (1) To define the impact of hCMV and the role of the hCMV
pUL97 kinase in regulating cellular Tip60 acetyltransferase during neural cell differentiation into functional 3-
dimensional tissues, and (2) to assess the hCMV kinase inhibitor maribavir in neural tissue. We hypothesize
that hCMV pUL97 manipulates Tip60 to stimulate viral DNA synthesis resulting in alteration of neural
tissue development and sensitization of differentiating cells to maribavir anti-hCMV activity. This will
be tested in two aims: Aim 1 Test the hypothesis that the contribution of pUL97 to hCMV infection is
dependent on tissue-specific expression of Tip60 isoforms during neurogenesis; and Aim 2 Test the
hypothesis that pUL97 kinase inhibition prevents hCMV spread in 3-dimensional human neural tissues and
allows uninfected human neural progenitor cells to differentiate into a spatial network of astrocytes and
synaptically-connected cortical neurons. A comprehensive repertoire of cellular and molecular biological
techniques combined with innovative approaches in tissue engineering and mass spectrometry-based
imaging will be used to study hCMV infection in developing cortical tissue.
Congenital hCMV infection can have devastating effects on children, pose significant challenges for
parents, and continues to be a significant burden on society. Regardless of the validity of our hypothesis,
these studies will uncover fundamental aspects of hCMV pUL97 kinase biology and Tip60’s contributions to
neurogenesis, hCMV infection, and antiviral susceptibility in a clinically relevant cell and tissue type.
项目摘要
人巨细胞病毒(hCMV)感染了世界上大部分人口,并建立了一个终身的
持续性感染定义为裂解和潜伏状态,hCMV仍然是一个重要的问题,
人体健康hCMV是美国非遗传性出生缺陷的主要原因,
世界如果病毒穿过胎盘屏障,hCMV在胎儿神经祖细胞中复制,
中枢神经系统损伤存在几种抗病毒治疗方法,但未被批准用于
由于毒性和潜在的致畸作用而导致妊娠。本文所述的合作项目
开始应用,以解决在理解潜在发病机制方面的重大缺陷
先天性hCMV感染和缺乏抗病毒方法。
hCMV表达一种病毒激酶pUL 97,它调节多种病毒和细胞过程,
被抗病毒化合物Maribavir抑制。pUL 97的一个靶标对hCMV复制很重要,
Maribavir活性是细胞Tip 60乙酰转移酶。Tip 60是一种肿瘤抑制因子,
许多病毒,并在组织发育过程中调节干细胞更新和分化。Tip 60是
以几种同种型表达,并且是较大的多蛋白Tip 60复合物的一部分,其中特异性功能
活性由相关蛋白决定。
本提案的目的有两个:(1)明确hCMV的影响和作用,
pUL 97激酶在神经细胞分化为功能性3-羟色胺过程中调节细胞Tip 60乙酰转移酶
三维组织,和(2)评估神经组织中的hCMV激酶抑制剂Maribavir。我们假设
hCMV pUL 97操纵Tip 60以刺激病毒DNA合成,导致神经细胞凋亡的改变。
组织发育和分化细胞对Maribavir抗hCMV活性的敏感性。这将
目的1检验pUL 97对hCMV感染的贡献是
依赖于神经发生过程中Tip 60亚型的组织特异性表达;目的2
假设pUL 97激酶抑制阻止hCMV在三维人神经组织中扩散,
允许未感染的人神经祖细胞分化成星形胶质细胞的空间网络,
突触连接的皮层神经元。一个全面的细胞和分子生物学
技术结合创新的方法在组织工程和质谱为基础
成像将用于研究发育中的皮质组织中的hCMV感染。
先天性hCMV感染可能对儿童产生破坏性影响,对儿童的健康构成重大挑战。
这对父母来说是一个沉重的负担,对社会来说是一个沉重的负担。不管我们的假设是否正确,
这些研究将揭示hCMV pUL 97激酶生物学的基本方面和Tip 60对
神经发生、hCMV感染和临床相关细胞和组织类型中的抗病毒易感性。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALLISON D EBERT其他文献
ALLISON D EBERT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALLISON D EBERT', 18)}}的其他基金
Motor neuron generation from SMA patient-derived induced pluripotent stem cells
SMA 患者来源的诱导多能干细胞产生运动神经元
- 批准号:
7641470 - 财政年份:2009
- 资助金额:
$ 38.5万 - 项目类别:
Motor neuron generation from SMA patient-derived induced pluripotent stem cells
SMA 患者来源的诱导多能干细胞产生运动神经元
- 批准号:
8239740 - 财政年份:2009
- 资助金额:
$ 38.5万 - 项目类别:
Motor neuron generation from SMA patient-derived induced pluripotent stem cells
SMA 患者来源的诱导多能干细胞产生运动神经元
- 批准号:
7942745 - 财政年份:2009
- 资助金额:
$ 38.5万 - 项目类别:
相似海外基金
Dissecting out differential molecular phenotypes across Lysine(K) AcetylTransferase mutations in mouse development
剖析小鼠发育过程中赖氨酸(K)乙酰转移酶突变的差异分子表型
- 批准号:
10727966 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Targeting lysine acetyltransferase MOF/KAT8 in lung cancer
靶向赖氨酸乙酰转移酶 MOF/KAT8 在肺癌中的作用
- 批准号:
10601761 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Defining the cell-type specific role of histone acetyltransferase KAT2a in nucleus accumbens D1 medium spiny neurons as a driver of cocaine use disorder
定义组蛋白乙酰转移酶 KAT2a 在伏隔核 D1 中型多棘神经元中作为可卡因使用障碍驱动因素的细胞类型特异性作用
- 批准号:
10679238 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Roles of lysine acetyltransferase 6 complexes in cerebral development and neurodevelopmental disorders
赖氨酸乙酰转移酶 6 复合物在大脑发育和神经发育障碍中的作用
- 批准号:
479754 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Operating Grants
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
开发用于癌基因驱动癌症的 p300/CBP 组蛋白乙酰转移酶抑制剂
- 批准号:
10344246 - 财政年份:2022
- 资助金额:
$ 38.5万 - 项目类别:
Examination of the Histone Acetyltransferase CBP in the Remodelling of Thermogenic Adipose Tissues
组蛋白乙酰转移酶 CBP 在生热脂肪组织重塑中的检测
- 批准号:
486467 - 财政年份:2022
- 资助金额:
$ 38.5万 - 项目类别:
Studentship Programs
Nuclear activity of carnitine acetyltransferase
肉毒碱乙酰转移酶的核活性
- 批准号:
RGPIN-2018-06089 - 财政年份:2022
- 资助金额:
$ 38.5万 - 项目类别:
Discovery Grants Program - Individual
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
开发用于癌基因驱动癌症的 p300/CBP 组蛋白乙酰转移酶抑制剂
- 批准号:
10627744 - 财政年份:2022
- 资助金额:
$ 38.5万 - 项目类别:
Characterizing the role of the NuA3 histone acetyltransferase complex during transcription
表征 NuA3 组蛋白乙酰转移酶复合物在转录过程中的作用
- 批准号:
557615-2021 - 财政年份:2022
- 资助金额:
$ 38.5万 - 项目类别:
Postdoctoral Fellowships
Structural and functional studies of histone acetyltransferase complexes
组蛋白乙酰转移酶复合物的结构和功能研究
- 批准号:
RGPIN-2018-03951 - 财政年份:2022
- 资助金额:
$ 38.5万 - 项目类别:
Discovery Grants Program - Individual